Clinical Trials Browser

Phase 2/3 × OTHER × titanium silicide × Clear all

NCT00639327 2011-06-28

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms